2026 Interventional Pulmonary - Diagnostic & Therapeutic Bronchoscopy

Wednesday, April 15, 2026, 8:30 AM - Saturday, April 18, 2026, 1:00 PM, Lahey Hospital & Medical Center, Burlington, MA


AMA PRA Category 1 Credits™ (27.00 hours), Non-Physician Attendance (27.00 hours)

This comprehensive post-graduate course is designed for experienced thoracic endoscopists and provides an in-depth review of advanced diagnostic and therapeutic techniques in interventional pulmonology. Topics include rigid and navigational bronchoscopy, EBUS-guided lung cancer detection and staging, airway and pleural interventions, bronchoscopic therapies for emphysema, and pulmonary nodule risk stratification and program development. The course highlights current evidence, emerging technologies, and practical application of a full range of interventional tools. Educational formats include lectures, case-based discussions, video instruction, and hands-on laboratory sessions utilizing low- and high-fidelity simulation.

1. Identify the indications, contraindications, and proper techniques for advanced interventional pulmonology procedures.
2. Discuss the principles and clinical applications of laser therapy, argon plasma coagulation, electrocautery, cryotherapy, and cryobiopsy.
3. Describe the pathophysiology of central airway obstruction and the role of endoscopic therapies and airway stenting in its management.
4. Manage benign and malignant airway diseases using advanced bronchoscopic techniques.
5. Define the role of TBNA, EBUSguided biopsy, cryobiopsy, and other advanced bronchoscopic modalities in the diagnosis and staging of lung cancer.
6. Describe pleural anatomy and the appropriate indications for medical thoracoscopy and indwelling pleural catheter placement in benign and malignant pleural disease.
7. Explain the indications and techniques for percutaneous dilatational tracheostomy and cricothyrotomy.
8. Develop management strategies for hemoptysis in the interventional pulmonology setting.
9. Apply current lung cancer screening and staging guidelines, including risk stratification of pulmonary nodules.
10. Describe the role of rigid bronchoscopy in the management of complex airway disease.
11. Identify relevant cytologic and molecular markers used in the diagnosis and management of lung cancer.
12. Explain the principles of navigational bronchoscopy and minimally invasive robotic bronchoscopic techniques using radiographic guidance.

Lahey Clinic Hospital, Inc. designates this live activity for a maximum of 27.00 AMA PRA Category 1 credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Cancellation Policy

Please note that cancellation fees vary depending on the activity. Cancellations must be made in writing, and refunds, minus the applicable cancellation fee, will be processed within 2 weeks. For cancellations made within 15 days or no-shows, the full registration fee may be forfeited. If you have any questions, please contact us at [email protected]

Accessibility Statement
 
Lahey Clinical Hospital Inc. is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME Conference Coordinator.

You are not logged in.

Please click the button below to login or create a new account before continuing.

Lahey Clinical Hospital, Inc. adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Mitigation of Relevant Financial Relationships

Lahey Hospital and Medical Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

W9 Form Exhibit at this Event